Cloudmed, an R1 company
Cloudmed was acquired by R1 RCM. Please visit us here: https://www.linkedin.com/company/r1-rcm.
Cloudmed was acquired by R1 RCM. Please visit us here: https://www.linkedin.com/company/r1-rcm.
Par8o, an R1 company was a healthcare startup acquired by R1 RCM. The company, now known as Cloudmed 340B Recovery, focuses on turning misclassified prescriptions into recovered 340B savings through ineligible claim and referral capture. Founded in 2011 and headquartered in the United States, the company operates in the Health Care industry. Its last recorded investment was a Private Equity Round at 18 October 2017, with Eir Partners and BKO Capital as the investors. The company's compliance-first solution is adaptable to any third-party administrator and contract pharmacy, with a special integration with the top two retail pharmacy chains, positioning the company as a valuable player in the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 2 |
|
18 Oct 2017 |
No recent news or press coverage available for Cloudmed, an R1 company.
We care about your data, and we'd love to use cookies make your experience better.